Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

References

• Fisch P, Malkovsky M, Braakman E, Sturm E, Bolhuis RL, Prieve A, Sosman JA, Lam VA, Sondel PM. Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med 1990; 171:1567–79; PMID:2185329; http://dx.doi.org/10.1084/jem.171.5.1567
   PubMed Web of Science ®Google Scholar
• Fournie JJ, Bonneville M. Stimulation of gamma delta T cells by phosphoantigens. Res Immunol 1996; 147:338–47; PMID:8876063; http://dx.doi.org/10.1016/0923-2494(96)89648-9
   PubMedGoogle Scholar
• Poccia F, Malkovsky M, Gougeon ML, Bonneville M, Lopez-Botet M, Fournie JJ, Colizzi V. Gammadelta T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules. J Leukoc Biol 1997; 62:287–91; PMID:9307066
   PubMed Web of Science ®Google Scholar
• Fournie JJ, Sicard H, Poupot M, Bezombes C, Blanc A, Romagne F, Ysebaert L, Laurent G. What lessons can be learned from gamma delta T cell-based cancer immunotherapy trials? Cell Mol Immunol 2013; 10:35–41; http://dx.doi.org/10.1038/cmi.2012.39
   PubMed Web of Science ®Google Scholar
• Meraviglia S, Lo Presti E, Dieli F, Stassi G. gammadelta T cell-based anticancer immunotherapy: progress and possibilities. Immunotherapy 2015; 7:949–51; PMID:26569071; http://dx.doi.org/10.2217/imt.15.68
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tanaka Y. gammadelta T Cell Immunotherapy-A Review. Pharmaceuticals (Basel) 2015; 8:40–61; PMID:25686210; http://dx.doi.org/10.3390/ph8010040
   PubMedGoogle Scholar
• Silva-Santos B, Serre K, Norell H. gammadelta T cells in cancer. Nat Rev Immunol 2015; 15:683–91; PMID:26449179; http://dx.doi.org/10.1038/nri3904
   PubMed Web of Science ®Google Scholar
• Shen-Orr SS, Gaujoux R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr Opin Immunol 2013; 25:571–8; PMID:24148234; http://dx.doi.org/10.1016/j.coi.2013.09.015
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015; 12:453–7; PMID:25822800; http://dx.doi.org/10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015; 21:938–45; PMID:26193342; http://dx.doi.org/10.1038/nm.3909
   PubMed Web of Science ®Google Scholar
• Pont F, Familiades J, Dejean S, Fruchon S, Cendron D, Poupot M, Poupot R, L'faqihi-Olive F, Prade N, Ycart B et al. The gene expression profile of phosphoantigen-specific human gammadelta T lymphocytes is a blend of alphabeta T-cell and NK-cell signatures. Eur J Immunol 2012; 42:228–40; PMID:21968650; http://dx.doi.org/10.1002/eji.201141870
   PubMed Web of Science ®Google Scholar
• Chtanova T, Newton R, Liu SM, Weininger L, Young TR, Silva DG, Bertoni F, Rinaldi A, Chappaz S, Sallusto F et al. Identification of T cell-restricted genes, and signatures for different T cell responses, using a comprehensive collection of microarray datasets. J Immunol 2005; 175:7837–47; PMID:16339519; http://dx.doi.org/10.4049/jimmunol.175.12.7837
   PubMed Web of Science ®Google Scholar
• Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M, Twité N, Goldman M, Marchant A, Willems F et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010; 207:807–21; PMID:20368575; http://dx.doi.org/10.1084/jem.20090348
   PubMed Web of Science ®Google Scholar
• Tosolini M, Algans C, Pont F, Ycart B, Fournie JJ. Large scale microarray profiling reveals four stages of immune escape in non-Hodgkin's lymphomas. Oncoimmunology 2016; 5(7):e1188246: in press; PMID:27622044; http://dx.doi.org/10.1080/2162402X.2016.1188246
   PubMed Web of Science ®Google Scholar
• Braza MS, Caraux A, Rousset T, Lafaye de Micheaux S, Sicard H, Squiban P, Costes V, Klein B, Rossi JF. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. J Immunol 2010; 184:134–40; PMID:19949101; http://dx.doi.org/10.4049/jimmunol.0901980
   PubMed Web of Science ®Google Scholar
• Gaulard P, de Leval L. Pathology of peripheral T-cell lymphomas: where do we stand? Semin Hematol 2014; 51:5–16; PMID:24468311; http://dx.doi.org/10.1053/j.seminhematol.2013.11.003
   PubMed Web of Science ®Google Scholar
• Przybylski GK, Wu H, Macon WR, Finan J, Leonard DG, Felgar RE, DiGiuseppe JA, Nowell PC, Swerdlow SH, Kadin ME et al. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn 2000; 2:11–9; PMID:11272897; http://dx.doi.org/10.1016/S1525-1578(10)60610-1
   PubMed Web of Science ®Google Scholar
• Gertner-Dardenne J, Castellano R, Mamessier E, Garbit S, Kochbati E, Etienne A, Charbonnier A, Collette Y, Vey N, Olive D. Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol 2012; 188:4701–8; PMID:22467661; http://dx.doi.org/10.4049/jimmunol.1103710
   PubMed Web of Science ®Google Scholar
• Gertner-Dardenne J, Fauriat C, Vey N, Olive D. Immunotherapy of acute myeloid leukemia based on gammadelta T cells. Oncoimmunology 2012; 1:1614–6; PMID:23264912; http://dx.doi.org/10.4161/onci.21512
   PubMed Web of Science ®Google Scholar
• Dean J, McCarthy D, Golden-Mason L, O'Farrelly C. Trephine biopsies are enriched for activated T/NK cells and cytotoxic T cells. Immunol Lett 2005; 99:94–102; PMID:15894117; http://dx.doi.org/10.1016/j.imlet.2005.01.008
   PubMed Web of Science ®Google Scholar
• Jack AS, Lu JQ. Immune cell infiltrates in the central nervous system tumors. Austin Neurosurgery: Open access 2015; 2(1):30
   Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545–50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960–4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
   PubMed Web of Science ®Google Scholar
• Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D, Church SE, Lafontaine L, Fischer M, Fredriksen T et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 2016; 44:698–711; PMID:26982367; http://dx.doi.org/10.1016/j.immuni.2016.02.025
   PubMed Web of Science ®Google Scholar
• Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One 2009; 4:e6098; PMID:19568420; http://dx.doi.org/10.1371/journal.pone.0006098
   PubMed Web of Science ®Google Scholar
• Newman AM, Alizadeh AA. High-throughput genomic profiling of tumor-infiltrating leukocytes. Curr Opin Immunol 2016; 41:77–84; PMID:27372732; http://dx.doi.org/10.1016/j.coi.2016.06.006
   PubMed Web of Science ®Google Scholar
• Karpinski P, Frydecka D, Sasiadek MM, Misiak B. Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder. Brain Behav Immun 2016; 54:194–200; PMID:26872421; http://dx.doi.org/10.1016/j.bbi.2016.02.005
   PubMed Web of Science ®Google Scholar
• Wang QH, Muller F, Kim H, Squatrito M, Millelsen T, Scarpace L, Barthel F, Lin YH, Satani N, Martinez-Ledesma E et al. Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment. bioRxiv 2016; http://dx.doi.org/https://doi.org/10.1101/052076
   Google Scholar
• Araujo JM, Prado A, Cardenas NK, Zaharia M, Dyer R, Doimi F, Bravo L, Pinillos L, Morante Z, Aguilar A et al. Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer. Oncotarget 2016; 7:20282–92; PMID:26958810; http://dx.doi.org/10.18632/oncotarget.7943
   PubMed Web of Science ®Google Scholar
• Vinayak S, Gray RJ, Adams S, Jensen KC, Manola J, Afghahi A, Goldstein LJ, Ford JM, Badve SS, Telli ML. Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105. J Clin Oncol 2014; 32: suppl.abstract 1000
   Web of Science ®Google Scholar
• Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Wevers E, Schwartz T, Hunborg P, Varvares MA, Hoft DF et al. Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J Immunol 2012; 189:5029–36; PMID:23034170; http://dx.doi.org/10.4049/jimmunol.1201892
   PubMed Web of Science ®Google Scholar
• Kowalczyk D, Skorupski W, Kwias Z, Nowak J. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma. Br J Urol 1997; 80:543–7; PMID:9352689; http://dx.doi.org/10.1046/j.1464-410X.1997.00408.x
   PubMedGoogle Scholar
• Bas M, Bier H, Schirlau K, Friebe-Hoffmann U, Scheckenbach K, Balz V, Whiteside TL, Hoffmann TK. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck. Oral Oncol 2006; 42:691–7; PMID:16527515; http://dx.doi.org/10.1016/j.oraloncology.2005.11.008
   PubMed Web of Science ®Google Scholar
• Daley D, Zambirinis CP, Seifert L, Akkad N, Mohan N, Werba G, Barilla R, Torres-Hernandez A, Hundeyin M, Mani VR et al. gammadelta T cells support pancreatic oncogenesis by restraining alphabeta T cell activation. Cell 2016; 166:1485-99 e15; http://dx.doi.org/10.1016/j.cell.2016.07.046
   PubMed Web of Science ®Google Scholar
• Goorha R, Bunin N, Mirro J, Jr, Murphy SB, Cross AH, Behm FG, Quertermous T, Seidman J, Kitchingman GR. Provocative pattern of rearrangements of the genes for the gamma and beta chains of the T-cell receptor in human leukemias. Proc Natl Acad Sci U S A 1987; 84:4547–51; PMID:2955409; http://dx.doi.org/10.1073/pnas.84.13.4547
   PubMed Web of Science ®Google Scholar
• Buccheri V, Matutes E, Dyer MJ, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7:919–27; PMID:8501986
   PubMed Web of Science ®Google Scholar
• Bachireddy P, Wu CJ. Understanding anti-leukemia responses to donor lymphocyte infusion. Oncoimmunology 2014; 3:e28187; PMID:25340010; http://dx.doi.org/10.4161/onci.28187
   PubMed Web of Science ®Google Scholar
• Aswald JM, Wang XH, Aswald S, Lutynski A, Minden MD, Messner HA, Keating A. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy? Cytometry B Clin Cytom 2006; 70:379–90; PMID:16977635; http://dx.doi.org/10.1002/cyto.b.20115
   PubMed Web of Science ®Google Scholar
• Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang Z, Wang C, Zhang Z, Xia W et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014; 40:785–800; PMID:24816404; http://dx.doi.org/10.1016/j.immuni.2014.03.013
   PubMed Web of Science ®Google Scholar
• Zocchi MR, Ferrarini M, Migone N, Casorati G. T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology 1994; 81:234–9; PMID:8157272
   PubMed Web of Science ®Google Scholar
• Essand M, Vasmatzis G, Brinkmann U, Duray P, Lee B, Pastan I. High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate. Proc Natl Acad Sci U S A 1999; 96:9287–92; PMID:10430935; http://dx.doi.org/10.1073/pnas.96.16.9287
   PubMed Web of Science ®Google Scholar
• McNeel DG, Malkovsky M. Immune-based therapies for prostate cancer. Immunol Lett 2005; 96:3–9; PMID:15585302; http://dx.doi.org/10.1016/j.imlet.2004.06.009
   PubMed Web of Science ®Google Scholar
• Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D'Asaro M, Gebbia N et al. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 2007; 67:7450–7; PMID:17671215; http://dx.doi.org/10.1158/0008-5472.CAN-07-0199
   PubMed Web of Science ®Google Scholar
• Dieli F, Caccamo N, Meraviglia S. Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and more. Curr Opin Investig Drugs 2008; 9:1089–94; PMID:18821471
   PubMedGoogle Scholar
• Lang JM, Wallace M, Becker JT, Eickhoff JC, Buehring B, Binkley N, Staab MJ, Wilding G, Liu G, Malkovsky M et al. A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy. Clin Genitourin Cancer 2013; 11:407–15; PMID:23835291; http://dx.doi.org/10.1016/j.clgc.2013.04.029
   PubMed Web of Science ®Google Scholar
• Rei M, Pennington DJ, Silva-Santos B. The emerging Protumor role of gammadelta T lymphocytes: implications for cancer immunotherapy. Cancer Res 2015; 75:798–802; PMID:25660949; http://dx.doi.org/10.1158/0008-5472.CAN-14-3228
   PubMed Web of Science ®Google Scholar
• Jin Z, Luo Q, Lu S, Wang X, He Z, Lai J, Chen S, Yang L, Wu X, Li Y. Oligoclonal expansion of TCR Vdelta T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia. J Hematol Oncol 2016; 9:126; PMID:27863523; http://dx.doi.org/10.1186/s13045-016-0353-3
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL et al. Signatures of mutational processes in human cancer. Nature 2013; 500:415–21; PMID:23945592; http://dx.doi.org/10.1038/nature12477
   PubMed Web of Science ®Google Scholar
• Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499:214–8; PMID:23770567; http://dx.doi.org/10.1038/nature12213
   PubMed Web of Science ®Google Scholar
• Li B, Li T, Pignon JC, Wang B, Wang J, Shukla SA, Dou R, Chen Q, Hodi FS, Choueiri TK et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genetics 2016; 48:725–32; PMID:27240091; http://dx.doi.org/10.1038/ng.3581
   PubMed Web of Science ®Google Scholar
• Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 2015; 160:48–61; PMID:25594174; http://dx.doi.org/10.1016/j.cell.2014.12.033
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell 2016; 165:276–87; PMID:27058662; http://dx.doi.org/10.1016/j.cell.2016.03.001
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Sci Transl Med 2015; 7:271ps1; PMC4690201; http://dx.doi.org/10.1126/scitranslmed.3010473
   PubMed Web of Science ®Google Scholar
• Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, Marchant A, Vermijlen D. Effector Vgamma9Vdelta2 T cells dominate the human fetal gammadelta T-cell repertoire. Proc Natl Acad Sci U S A 2015; 112:E556–65; PMID:25617367; http://dx.doi.org/10.1073/pnas.1412058112
   PubMed Web of Science ®Google Scholar
• Bezanson J, Karpinski S, Shah VB, Edelman A. Julia: A fast dynamic language for technical computing. eprint arXiv:12095145 2012.
   Google Scholar
• Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9:811–8; PMID:2218183; http://dx.doi.org/10.1002/sim.4780090710
   PubMed Web of Science ®Google Scholar
• Therneau TM, Grambsch PM. Modeling survival data: Extending the cox model. New York: Springer, 2000.
   Google Scholar